NCT03950986 Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System Status COMPLETED Phase NA
NCT03903718 Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza Status WITHDRAWN Phase PHASE2
NCT03901001 Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza Status RECRUITING Phase PHASE3
NCT03900988 Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia Status RECRUITING Phase PHASE3
NCT03898986 The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets Status COMPLETED Phase PHASE1
NCT03898973 Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood Status WITHDRAWN Phase PHASE4
NCT03884296 Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood Status WITHDRAWN Phase PHASE4
NCT03883113 Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model Status COMPLETED Phase PHASE2
NCT03880474 Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults Status TERMINATED Phase PHASE2
NCT03849560 Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers Status COMPLETED Phase PHASE2/PHASE3
NCT03845231 Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular Route Status COMPLETED Phase PHASE2
NCT03830905 Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI Status COMPLETED Phase PHASE2
NCT03830684 A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza Fever Status UNKNOWN Phase PHASE2
NCT03826719 Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers Status COMPLETED Phase PHASE1/PHASE2
NCT03816878 Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals Status COMPLETED Phase PHASE1